Loading, please wait....jpg)
.jpg)
The Premier July 24, 2024 CE webinar will be held from 12 - 1 pm EDT. We are pleased to provide one (1) 60-minute application-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
UPDATES GLP-1 & GIP AGONISTS FOR WEIGHT LOSS
SPEAKERS:
Melissa Lipari, PharmD, BCACP, Associate Professor (Clinical), Dept. of Pharmacy Practice, Clinical Pharmacy Specialist, Ambulatory Care, Ascension St. John Hospital, Detroit, MI
Alison Lobkovich, PharmD, Assistant Professor (Clinical), Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI
Pramodini Kale-Pradhan, Pharm, FCCP, FIDSA, Professor (Clinical), Pharmacy Practice, Clinical Pharmacy Specialist, Infectious Diseases, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI
ACPE Universal Activity Number 0122-0000-24-024-L01-P [0.1 CEU] [1 Contact Hr.] (Application-based CE)
Date: Jul 24, 2024 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Jul 24, 2024 12:10 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Registration closes on Jul 24, 2024
at 12:10 PM
Registration Closed
Objectives
- Choose whether a patient is a candidate for GLP-1 and GLP-1/GIP agonists for weight loss
- Discuss the evidence supporting the use of GLP-1 and GLP-1/GIP agonists for weight loss
- Interpret the efficacy and safety of GLP-1 and GLP-1/GIP agonists
- When given a patient case, design a pharmacotherapeutic regimen for a patient with obesity
Speaker(s)/Author(s)
|
Alison Lobkovich, PharmD, Assistant Professor (Clinical), Pharmacy Practice
|
|
|
Melissa Lipari, PharmD, BCACP
|
|
|
Pramodini Kale-Pradhan, Pharm, FCCP, FIDSA, Professor (Clinical), Clinical Pharmacy Specialist
|